|
GTF2F2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.546200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.165960E-01 |
| Normal-vs-Stage2 |
3.975400E-01 |
| Normal-vs-Stage3 |
3.051200E-01 |
| Normal-vs-Stage4 |
9.067400E-01 |
| Stage1-vs-Stage2 |
5.062100E-02 |
| Stage1-vs-Stage3 |
7.247000E-01 |
| Stage1-vs-Stage4 |
3.257000E-01 |
| Stage2-vs-Stage3 |
1.011970E-01 |
| Stage2-vs-Stage4 |
3.876200E-01 |
| Stage3-vs-Stage4 |
4.697400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.064000E-01 |
| Normal-vs-AfricanAmerican |
5.715000E-01 |
| Normal-vs-Asian |
1.542210E-01 |
| Caucasian-vs-AfricanAmerican |
9.408400E-01 |
| Caucasian-vs-Asian |
4.566600E-01 |
| AfricanAmerican-vs-Asian |
6.603400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.174400E-01 |
| Normal-vs-Female |
1.455410E-01 |
| Male-vs-Female |
1.945040E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.111900E-02 |
| Normal-vs-Age(41-60Yrs) |
6.521000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.967200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.093000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.483600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.643700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.526400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.832400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.200200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.160600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.602400E-03 |
| Classical-VS-Follicular |
1.047960E-01 |
| Classical-VS-Other |
3.923200E-01 |
| Classical-VS-Normal |
2.006800E-01 |
| Tall-VS-Follicular |
1.800030E-03 |
| Tall-VS-Other |
9.960400E-01 |
| Tall-VS-Normal |
1.096150E-03 |
| Follicular-VS-Other |
1.053430E-01 |
| Follicular-VS-Normal |
5.805600E-01 |
| Other-VS-Normal |
2.897800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.069600E-01 |
| Normal-vs-N1 |
5.241000E-01 |
| N0-vs-N1 |
4.386800E-01 |
|
|
